These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

363 related articles for article (PubMed ID: 11641241)

  • 1. Oculocutaneous albinism types 1 and 3 are ER retention diseases: mutation of tyrosinase or Tyrp1 can affect the processing of both mutant and wild-type proteins.
    Toyofuku K; Wada I; Valencia JC; Kushimoto T; Ferrans VJ; Hearing VJ
    FASEB J; 2001 Oct; 15(12):2149-61. PubMed ID: 11641241
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Tyrosinase processing and intracellular trafficking is disrupted in mouse primary melanocytes carrying the underwhite (uw) mutation. A model for oculocutaneous albinism (OCA) type 4.
    Costin GE; Valencia JC; Vieira WD; Lamoreux ML; Hearing VJ
    J Cell Sci; 2003 Aug; 116(Pt 15):3203-12. PubMed ID: 12829739
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The etiology of oculocutaneous albinism (OCA) type II: the pink protein modulates the processing and transport of tyrosinase.
    Toyofuku K; Valencia JC; Kushimoto T; Costin GE; Virador VM; Vieira WD; Ferrans VJ; Hearing VJ
    Pigment Cell Res; 2002 Jun; 15(3):217-24. PubMed ID: 12028586
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Tyrp1 and oculocutaneous albinism type 3.
    Sarangarajan R; Boissy RE
    Pigment Cell Res; 2001 Dec; 14(6):437-44. PubMed ID: 11775055
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Carbohydrates act as sorting determinants in ER-associated degradation of tyrosinase.
    Svedine S; Wang T; Halaban R; Hebert DN
    J Cell Sci; 2004 Jun; 117(Pt 14):2937-49. PubMed ID: 15161941
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Normal tyrosine transport and abnormal tyrosinase routing in pink-eyed dilution melanocytes.
    Potterf SB; Furumura M; Sviderskaya EV; Santis C; Bennett DC; Hearing VJ
    Exp Cell Res; 1998 Oct; 244(1):319-26. PubMed ID: 9770375
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Direct interaction of tyrosinase with Tyrp1 to form heterodimeric complexes in vivo.
    Kobayashi T; Hearing VJ
    J Cell Sci; 2007 Dec; 120(Pt 24):4261-8. PubMed ID: 18042623
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Tyrosinase-related proteins suppress tyrosinase-mediated cell death of melanocytes and melanoma cells.
    Rad HH; Yamashita T; Jin HY; Hirosaki K; Wakamatsu K; Ito S; Jimbow K
    Exp Cell Res; 2004 Aug; 298(2):317-28. PubMed ID: 15265682
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Soluble tyrosinase is an endoplasmic reticulum (ER)-associated degradation substrate retained in the ER by calreticulin and BiP/GRP78 and not calnexin.
    Popescu CI; Paduraru C; Dwek RA; Petrescu SM
    J Biol Chem; 2005 Apr; 280(14):13833-40. PubMed ID: 15677452
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Endoplasmic reticulum retention is a common defect associated with tyrosinase-negative albinism.
    Halaban R; Svedine S; Cheng E; Smicun Y; Aron R; Hebert DN
    Proc Natl Acad Sci U S A; 2000 May; 97(11):5889-94. PubMed ID: 10823941
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The molecular basis of oculocutaneous albinism type 1 (OCA1): sorting failure and degradation of mutant tyrosinases results in a lack of pigmentation.
    Toyofuku K; Wada I; Spritz RA; Hearing VJ
    Biochem J; 2001 Apr; 355(Pt 2):259-69. PubMed ID: 11284711
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Tyrosinase and ocular diseases: some novel thoughts on the molecular basis of oculocutaneous albinism type 1.
    Ray K; Chaki M; Sengupta M
    Prog Retin Eye Res; 2007 Jul; 26(4):323-58. PubMed ID: 17355913
    [TBL] [Abstract][Full Text] [Related]  

  • 13. l-tyrosine induces melanocyte differentiation in novel pink-eyed dilution castaneus mouse mutant showing age-related pigmentation.
    Hirobe T; Ishikawa A
    J Dermatol Sci; 2015 Dec; 80(3):203-11. PubMed ID: 26475433
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Melanosomal defects in melanocytes from mice lacking expression of the pink-eyed dilution gene: correction by culture in the presence of excess tyrosine.
    Rosemblat S; Sviderskaya EV; Easty DJ; Wilson A; Kwon BS; Bennett DC; Orlow SJ
    Exp Cell Res; 1998 Mar; 239(2):344-52. PubMed ID: 9521852
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Regulation of tyrosinase processing and trafficking by organellar pH and by proteasome activity.
    Watabe H; Valencia JC; Yasumoto K; Kushimoto T; Ando H; Muller J; Vieira WD; Mizoguchi M; Appella E; Hearing VJ
    J Biol Chem; 2004 Feb; 279(9):7971-81. PubMed ID: 14634018
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Mutation in and lack of expression of tyrosinase-related protein-1 (TRP-1) in melanocytes from an individual with brown oculocutaneous albinism: a new subtype of albinism classified as "OCA3".
    Boissy RE; Zhao H; Oetting WS; Austin LM; Wildenberg SC; Boissy YL; Zhao Y; Sturm RA; Hearing VJ; King RA; Nordlund JJ
    Am J Hum Genet; 1996 Jun; 58(6):1145-56. PubMed ID: 8651291
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Tyrosinase stabilization by Tyrp1 (the brown locus protein).
    Kobayashi T; Imokawa G; Bennett DC; Hearing VJ
    J Biol Chem; 1998 Nov; 273(48):31801-5. PubMed ID: 9822646
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Biallelic mutations in L-dopachrome tautomerase (DCT) cause infantile nystagmus and oculocutaneous albinism.
    Volk AE; Hedergott A; Preising M; Rading S; Fricke J; Herkenrath P; Nürnberg P; Altmüller J; von Ameln S; Lorenz B; Neugebauer A; Karsak M; Kubisch C
    Hum Genet; 2021 Aug; 140(8):1157-1168. PubMed ID: 33959807
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Mislocalization of melanosomal proteins in melanocytes from mice with oculocutaneous albinism type 2.
    Manga P; Boissy RE; Pifko-Hirst S; Zhou BK; Orlow SJ
    Exp Eye Res; 2001 Jun; 72(6):695-710. PubMed ID: 11384158
    [TBL] [Abstract][Full Text] [Related]  

  • 20. In vitro characterization of the intramelanosomal domain of human recombinant TYRP1 and its oculocutaneous albinism type 3-related mutant variants.
    Dolinska MB; Anderson DE; Sergeev YV
    Protein Sci; 2023 Jan; 32(1):e4518. PubMed ID: 36412553
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 19.